Skip to main content
Free access
Research Article
10 July 2019

Awareness and acceptability of Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials core outcome set for chronic pain among surveyed neuropathic pain authors

Abstract

Aim: We assessed the knowledge and adoption of Initiative on Methods, Measurement and Pain Assessment in Clinical Trials (IMMPACT)-recommended core outcome set (COS) and core outcome measures (COM) among authors of systematic reviews (SR) and randomized controlled trials (RCT) about interventions for neuropathic pain (NeuP). Methods: NeuP SR and RCT authors identified via a systematic literature search were surveyed. Results: The response rate was low. Although majority of respondents were familiar with the IMMPACT COS, only 61% of SR authors and 40% of RCT authors used the COS. The main perceived obstacle that prevented the adoption of the COS was the lack of awareness of the full IMMPACT COS. Conclusion: The adoption of IMMPACT-recommended COS and COM among NeuP authors was inadequate and their appropriateness needs to be further evaluated.

Supplementary Material

File (suppl_data.zip)

References

1.
Tunis SR, Clarke M, Gorst SL et al. Improving the relevance and consistency of outcomes in comparative effectiveness research. J. Comp. Eff. Res. 5(2), 193–205 (2016).
2.
Williamson PR, Altman DG, Blazeby JM et al. Developing core outcome sets for clinical trials: issues to consider. Trials 13, 132–132 (2012).
3.
Turk DC, Dworkin RH, Allen RR et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 106(3), 337–345 (2003).
4.
Dworkin RH, Turk DC, Farrar JT et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113(1–2), 9–19 (2005).
5.
Dosenovic S, Jelicic Kadic A, Miljanovic M et al. Interventions for neuropathic pain: an overview of systematic reviews. Anesth. Analg. 125(2), 643–652 (2017).
6.
Puljak L, Dosenovic S, Boric K. Importance of consistent outcomes in randomized controlled trials and systematic reviews about anesthesiology and pain. Pain Manag. 8(4), 251–253 (2018).
7.
Dosenovic S, Jelicic Kadic A, Jeric M et al. Efficacy and safety outcome domains and outcome measures in systematic reviews of neuropathic pain conditions. Clin. J. Pain 34(7), 674–684 (2018).
8.
Kirkham JJ, Boers M, Tugwell P, Clarke M, Williamson PR. Outcome measures in rheumatoid arthritis randomised trials over the last 50 years. Trials 14(1), 324 (2013).
9.
Kirkham JJ, Clarke M, Williamson PR. A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritis. BMJ 357 j2262 (2017).
10.
The US FDA. Guidance for industry: clinical development programs for drugs, devices, and biological products for the treatment of rheumatoid arthritis (RA) (1999). www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071579.pdf
11.
European Medicines Agency. Guideline on the clinical development of medicinal products intended for the treatment of pain (2016). www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-development-medicinal-products-intended-treatment-pain-first-version_en.pdf
12.
Smith TO, Mansfield M, Hawker GA et al. Uptake of the OMERACT-OARSI hip and knee osteoarthritis core outcome set: review of randomized controlled trials from 1997 to 2017. J. Rheumatol. (2019) (Epub ahead of print).
13.
Krsticevic M, Dosenovic S, Dimcea DA et al. Outcome domains, outcome measures and characteristics of randomized controlled trials testing non-surgical interventions for osteoarthritis. J. Rheumatol. (2019) (Epub ahead of print).
14.
Araújo F, Cordeiro I, Branco JC, Falzon L, Buchbinder R, Ramiro S. Outcomes assessed in trials of gout and accordance with OMERACT-proposed domains: a systematic literature review. Rheumatology (Oxford) 54(6), 981–993 (2014).
15.
Copsey B, Hopewell S, Becker C, Cameron ID, Lamb SE. Appraising the uptake and use of recommendations for a common outcome data set for clinical trials: a case study in fall injury prevention. Trials 17(1), 131 (2016).
16.
Boric K, Boric M, Dosenovic S et al. Authors’ lack of awareness and use of core outcome set on postoperative pain in children is hindering comparative effectiveness research. J. Comp. Eff. Res. 7(5), 463–470 (2018).
17.
NHS. National Institute for Health Research. Supporting information for applicants applying to the HTA programme (2018). www.nihr.ac.uk/funding-and-support/documents/current-funding-opportunities/hta/hta-supporting-information.pdf
18.
COMET. Core outcome measures in effectiveness trials initiative (2017). www.comet-initiative.org/
19.
Chan A-W, Tetzlaff JM, Gøtzsche PC et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 346, e7586 (2013).
20.
Gorst SL, Gargon E, Clarke M, Blazeby JM, Altman DG, Williamson PR. Choosing important health outcomes for comparative effectiveness research: an updated review and user survey. PLoS ONE 11(1), e0146444 (2016).